Relmada Therapeutics, Inc. · NASDAQ:RLMD
Spruce Street Capital LP reported a 5.57% stake in Relmada Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Spruce Street Capital LP reported a 5.57% stake in Relmada Therapeutics, Inc., 4,086,181 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.57%
- Shares
- 4,086,181
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Spruce Street Capital LP | 5.57% | 4,086,181 |
| Alex R. Rosen | 5.57% | 4,086,181 |
| Simon Basseyn | 5.57% | 4,086,181 |
Source
Related
- Relmada Therapeutics, Inc.
- Spruce Street Capital LP
- Relmada Therapeutics, Inc. shareholders
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026